PHARMACOKINETICS OF BRIVARACETAM IN SUBJECTS WITH SEVERE RENAL IMPAIRMENT

被引:0
|
作者
Stockis, A. [1 ]
Jacobs, T. [1 ]
Leonard, M. [1 ]
Sargentini-Maier, M. L. [1 ]
机构
[1] UCB Pharma SA, Braine Lalleud, Belgium
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:122 / 123
页数:2
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF IODAMIDE IN NORMAL SUBJECTS AND IN PATIENTS WITH RENAL IMPAIRMENT
    DIFAZIO, LT
    SINGHVI, SM
    HEALD, AF
    MCKINSTRY, DN
    BROSMAN, SA
    GILLENWATER, JY
    WILLARD, DA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 18 (01): : 35 - 41
  • [42] Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome
    Appel-Dingemanse, S
    Smith, T
    Merz, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (03): : 312 - 318
  • [43] Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment
    Michael J. Roy
    Keith A. Erdman
    Anura T. Abeyratne
    Lisa C. Plumb
    Kenneth Lasseter
    Dennis S. Riff
    James J. Keirns
    Clinical Pharmacokinetics, 2013, 52 : 385 - 395
  • [44] Pharmacokinetics and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
    Granhall, Charlotte
    Rethy, Agnes
    Sondergaard, Flemming L.
    Thomsen, Mette
    Anderson, Thomas W.
    DIABETES, 2017, 66 : A317 - A318
  • [45] Pharmacokinetics of insulin detemir in subjects with renal or hepatic impairment
    Jacobsen, LV
    Popescu, G
    Plum, A
    DIABETES, 2002, 51 : A102 - A102
  • [46] PHARMACOKINETICS OF CEFEPIME DIHYDROCHLORIDE ARGININE IN SUBJECTS WITH RENAL IMPAIRMENT
    CRONQVIST, J
    NILSSONEHLE, I
    OQVIST, B
    NORRBY, SR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) : 2676 - 2680
  • [47] The pharmacokinetics and safety of desvenlafaxine in subjects with chronic renal impairment
    Nichols, A. I.
    Richards, L. S.
    Behrle, J. A.
    Posener, J. A.
    McGrory, S. B.
    Paul, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (01) : 3 - 13
  • [48] PHARMACOKINETICS OF FAMCICLOVIR IN SUBJECTS WITH VARYING DEGREES OF RENAL IMPAIRMENT
    BOIKE, SC
    PUE, MA
    FREED, MI
    AUDET, PR
    FAIRLESS, A
    ILSON, BE
    ZARIFFA, N
    JORKASKY, DK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) : 418 - 426
  • [49] Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis
    Chen, Nionhang
    Lau, Henry
    Kon, Linghui
    Kumar, Gondi
    Zeldis, Jerome B.
    Knight, Robert
    Laskin, Oscar L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (12): : 1466 - 1475
  • [50] Fesoterodine pharmacokinetics in subjects with renal impairment vs. healthy subjects
    Malhotra, Bimal
    Wood, Nolan
    Guna, Zhonghong
    Gandelman, Kuan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 998 - 998